This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tissue engineering in age-related macular degeneration: a mini-review
Journal of Biological Engineering Open Access 16 May 2022
-
Light-induced Nrf2−/− mice as atrophic age-related macular degeneration model and treatment with nanoceria laden injectable hydrogel
Scientific Reports Open Access 10 October 2019
-
Proteomic analysis of retinal pigment epithelium cells after exposure to UVA radiation
BMC Ophthalmology Open Access 02 August 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Visiongain. Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013–2023. (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Evans, J., Syed, B. New hope for dry AMD?. Nat Rev Drug Discov 12, 501–502 (2013). https://doi.org/10.1038/nrd4038
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4038
This article is cited by
-
Tissue engineering in age-related macular degeneration: a mini-review
Journal of Biological Engineering (2022)
-
Proteomic analysis of retinal pigment epithelium cells after exposure to UVA radiation
BMC Ophthalmology (2019)
-
Light-induced Nrf2−/− mice as atrophic age-related macular degeneration model and treatment with nanoceria laden injectable hydrogel
Scientific Reports (2019)
-
Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro
Archives of Pharmacal Research (2016)
-
Treatment of Geographic Atrophy: What’s on the Horizon?
Current Ophthalmology Reports (2014)